🧬 Researchers have uncovered a new therapeutic vulnerability in one of the most aggressive childhood leukaemias. The preclinical study, published in Blood, was led by the Josep Carreras Institute, GENyO, University of Granada and IRSJD. 🔗 www.carrerasresearch.org/en/news/stud...

📢 Registration is now open for the IJC Symposium 2026! Join us on 5–6 Nov in Barcelona to explore the latest advances in the immunology of haematological malignancies and future therapies for blood cancers. 🧬 Free registration 📄 Abstract submissions open 🔗 carrerasresearch.org/en/p/immunit...

👩‍🔬 ¿Las claves de una carrera científica de éxito? “Un buen equipo y esforzarse en conseguir la excelencia”, Dra. @bmjavierre.bsky.social . @raciencias.bsky.social y Mastercard reconocen a la Dra. Javierre en su 🏅 #PremioMujerYCiencia. 🔗 www.carrerasresearch.org/es/noticias/...

The @achilles-dn.bsky.social, coordinated by Dr Laura Belver, brings together 15 centres in 12 countries to train PhD researchers in experimental haemato-oncology and accelerate translational blood cancer research. 🔗 Learn more: www.carrerasresearch.org/en/news/the-...

📢 Join us on Monday 9 Feb 2026 for a high-level symposium on Follicular Lymphoma! The symposium will bring together leading experts to share discoveries and drive projects that improve treatments and quality of life of patients with FL. 👉 Register in-person or online: forms.office.com/e/Cqix1YVB8b

Un placer recibir la visita de CRIS contra el Cáncer en el IJC. Intercambiamos visiones, compartimos nuestro plan estratégico e iniciativas clave y exploramos cómo unir fuerzas para acelerar el impacto frente a los cánceres de la sangre 🔬 🤝

🔬 Dr Alex Vaquero (@vaquerolab.bsky.social) will study the restoration of PAX5 balance in leukemic cells as a new tool in the fight against B-ALL thanks to the support from @caixaresearch.bsky.social 🙌 Know more about their project 👇 www.carrerasresearch.org/en/news/rest...

¿Qué avances científicos nos esperan en el ámbito del envejecimiento? No te pierdas la mesa redonda “El reto de hacerse mayor” para descubrir cómo la ciencia está cambiando nuestra forma de envejecer. 📅 6 Nov, 18:30 📍 Auditorio @the_prbb BCN 🎟️ Entrada libre 👩‍🔬Moderado por @vrodillab.bsky.social

The Josep Carreras Institute made its mark at #BIOSPAIN2025! Our team fostered key collaborations 🤝, shared new leadership initiatives 💡and reinforced IJC’s position as a leading centre in #BloodCancer research 🔬 🔗 www.carrerasresearch.org/en/news/the-...

We’re proud to host the 2nd @securedproject.bsky.social Demonstration Workshop at IJC on 3-4 December! A unique opportunity for research, healthcare and cybersecurity experts to explore cutting-edge solutions for secure biomedical data processing. Register here!🔗 secured-project.eu/2nd-demo-wor...

🚨 We are hiring! A #Postdoc position is open in the Chromatin Biology Lab to work on Sirtuins & Leukemia 🧬 If you are up to the challenge join our @vaquerolab.bsky.social team at @CarrerasIJC.bsky.social Apply here 👉 careers.carrerasresearch.org/jobs/6549033-v… Sirtuins rule! 🦾

VAC_82_2025 - POSTDOCTORAL RESEARCHER (Chromatin biology laboratory) - Institut de Recerca contra la Leucèmia Josep Carreras

Join the Josep Carreras Leukaemia Research Institute and contribute to our mission of innovating and advancing the fight against leukaemia and other hematologic diseases.

careers.carrerasresearch.org

IDIBAPS SEMINAR Malignant transformation of the immune system and therapeutic solutions 📆6/10 15h 👨‍🔬Ari Melnick, @carrerasijc.bsky.social  📍 Esteve Auditorium, CEK 👉https://f.mtr.cool/earftanszd

Our common goal: curing childhood leukaemia 🤝 The Josep Carreras Institute, the Josep Carreras Foundation and the Sant Joan de Déu Research Institute launch a joint programme to advance research into paediatric blood cancers 🔬 🔗 Read more: www.carrerasresearch.org/en/news/new-...

📢 La unidad de Comunicación del IJC ha sido acreditada como Unidad de Cultura Científica y de la Innovación (UCC+I) por #FECYT. Un paso clave para seguir acercando la ciencia a la sociedad🔬 🔗 www.carrerasresearch.org/es/noticias/...

La Dra. Sònia Guil nos habla de su investigación en #SíndromeDeRett y del nuevo fármaco que están desarrollando con el objetivo de revertir sus síntomas. No te pierdas su entrevista en 'A golpe de bit' en #RNE 📻 Escúchala aquí 👇 www.rtve.es/play/audios/...

QTX153, el fármaco español contra el Síndrome de Rett

El Síndrome de Rett es un trastorno genético neurológico poco frecuente que afecta a la forma en la que se desarrolla el cerebro.

rtve.es

Congratulations, Dr Obiols! 👩‍🔬 Mireia Obiols, researcher at the @jlsardinalab.bsky.social, has successfully defended her #PhD thesis today at the IJC Auditorium. Proud of your dedication and hard work 💪

🚨New research by @jlsardinalab.bsky.social and Gemma Valcarcel published at Science Advances uses a CRISPR technology to control immune cell response to inflammation in the lab. 🔗 Read more: www.carrerasresearch.org/en/news/epig...

Last #YoungResearchers Seminars before the summer break! 👩‍🔬 Our talented researchers Mar Gusi (Maribel Parra's lab) and Alba Vidal (Anna Bigas' lab) gave excellent presentations yesterday, sharing their work to the rest of the IJC community. We’ll be back in September with more inspiring seminars✨

📢 Registration open! Explore the latest advances in cellular #senescence at the upcoming International Conference of @senescel.org 🧬 📅 06-07 November 2025 📍 Barcelona More information ⬇️ senescel2025.senescel.org Co-organised by IJC Group Leader Dr. Verónica Rodilla ‪@vrodillab.bsky.social‬

🧬 New research from Pablo Menéndez's lab presents a novel CAR-T cells therapy designed to target 2️⃣ specific markers of T-ALL: the CD1a and CCR9 proteins. Preclinical results show high efficacy and safety in the lab. 🔗 carrerasresearch.org/en/news/a-ne... 🤝 ISS Aragon, OneChain Immunotherapeutics

El Dr. @manelesteller.bsky.social , de l’IJC, i el Dr. @macips01.bsky.social reben el premi Jaume Aiguader i Miró de l'Acadèmia de Ciències Mèdiques i de la Salut per “El secret de la vida eterna” 📖 🔗 www.carrerasresearch.org/ca/noticies/...

💬🔬 Yesterday we held another inspiring Group Leaders Seminar at the Josep Carreras Institute Dr Tomàs Navarro and Dr Gaël Roué shared deep insights into the biology and treatment of B-Lymphomas 👏 Sharing science is key to moving forward together 🚀

This Friday, do not miss Dr Rouault-Pierre's Invited Lecture! 💬 "Metabolic intervention in Myelodysplastic Neoplasm; Endoplasmic Reticulum Stress governs a splicing programme in healthy and malignant cells" 🗓️ 23 May, 12pm CEST 📍IJC Auditorium Online at 👉 us06web.zoom.us/webinar/regi...

🔬🌍 Today, on #ClinicalTrialsDay, we celebrate the power of research to save lives A hopeful milestone: In a phase I clinical trial, our new CAR-T therapy has shown promising results in patients with a highly resistant lymphoma 📄 Read the full story: www.carrerasresearch.org/en/news/new-...

Yesteday we officially welcomed Dr Ari Melnick, the new Director of the Josep Carreras Institute. 💬 "I see us as a team united in our purpose to eradicate blood cancers." He reaffirmed his commitment to scientific progress and collaborative growth in front of #IJC community 🚀

New study co-led by @manelesteller.bsky.social shows that epigenetic profiling identifies two distinct subtypes of Burkitt lymphoma, allowing early prediction of disease aggressiveness. This could help tailor treatment strategies from diagnosis. 🧬📈 👉 www.carrerasresearch.org/en/news/epig...

Epigenetics predicts the aggressiveness of Burkitt Lymphoma, a common paediatric tumour in developing countries

Researchers of the Cancer Epigenetics group at the Josep Carreras Leukaemia Research Institute have discovered that patients with Burkitt lymphoma — a common...

carrerasresearch.org

❗️🔬 New research from @scuartero.bsky.social's lab reveals that CEBPA mutations in #AML increase resistance to inflammation but make cells more vulnerable to protein-folding stress, opening the door to new treatment strategies. ➡️ www.carrerasresearch.org/en/news/a-co...

New CD30-targeted CAR-T therapy shows 100% overall response and 50% complete remission in Refractory Hodgkin Lymphoma patients 👉 carrerasresearch.org/en/news/new-... 🔬 Led by Dr. Javier Briones, PI at #IJC and @irsantpau.bsky.social @hospitalsantpau.bsky.social 📝 @bloodjournal.bsky.social

We're pleased to announce that Dr Ari Melnick has been appointed new Director of the Josep Carreras Institute. Dr Melnick will lead IJC in our mission to advance #research in #leukaemia and other malignant blood diseases. Read the full release here: www.carrerasresearch.org/en/news/dr-a...

🧬 Genetic susceptibility to cancer explained. New study by Eduard Porta's lab at @cellpress.bsky.social describes 119 germline variants with significant contribution to cancer onset and progession. ➡️ carrerasresearch.org/en/news/new-...